The FDA reversed its initial refusal and will now review Moderna's mRNA flu vaccine for adults. The earlier rejection had sparked criticism about potential political influence on vaccine policy under the current administration.
Explore Related Nuggs
Additional details & advanced features are only available through the NewsNuggs iOS app, download it from the app store today!